Project Grant C06OD039902
Award Date 9/15/25
Completion Date 3/31/28
Dollars Obligated $4M
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98109, USA
Similar Awards
- The U.S. National Institutes of Health (NIH), through its Office of Research Infrastructure Programs (ORIP), awarded a Project Grant under the Research Infrastructure Programs (CFDA 93.351) to the Fred Hutchinson Cancer Center in Seattle, Washington. The $2,000,000 grant, with a performance period from July 15, 2025 to July 14, 2026, will fund the replacement of the center's aging high-performance computing (HPC) cluster. The new 130-node, 7,799-core, 192 TB RAM HPC system with 1,753,088 CUDA...
- This federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), is supporting research at the Fred Hutchinson Cancer Center in Seattle, WA to target epidermal plasticity to prevent triple negative breast cancer recurrence. The $1,173,081 award, with a performance period from April 1, 2025 to March 31, 2029, will fund cutting-edge biomedical research focused on developing innovative medical solutions to address...
- Fred Hutchinson Cancer Center was awarded a $898,342 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to exploit real-world clinical genomic data to discover biomarkers and address outcome disparity for prostate cancer. Through this award, Fred Hutchinson Cancer Center will leverage existing genomic and clinical data to identify biomarkers...
- This Project Grant award from the National Institutes of Health (NIH), under the Construction Support program (CFDA 93.352), provides $15,715,230 to the University of Massachusetts Chan Medical School (UMass Chan) to renovate existing space and construct a new Biosafety Level 3 (BSL-3) laboratory for viral pathogen research. The new BSL-3 facility will address the increased demand for this specialized research infrastructure at UMass Chan, which has become a leading institute for studying...
- The U.S. Defense Health Agency awarded a $5,149,107 Project Grant to the Fred Hutchinson Cancer Center in Seattle, WA, under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at "Defining Human Correlates of Super-Evasive Disseminated Tumor Cells, Their Pathological Relevance and How to Eradicate Them" over the period of July 1, 2025 to June 30, 2029. The research will be conducted by the prominent non-profit medical research...
- This federal Project Grant award of $484,000.00 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to the Fred Hutchinson Cancer Center in Seattle, Washington. The award will support a research project titled "Defining Mechanisms that Underlie Well-Controlled Translation Initiation" over the period from September 1, 2025 to August 31, 2030. The project aims to use innovative...
- The federal Project Grant award, ID HT94252411040, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $879,692 award, with a performance period from September 30, 2024 to September 29, 2027, supports the Fred Hutchinson Cancer Center's research on "Combinatorial Phenotype-Targeted Therapy to Overcome Mechanisms Driving Prostate Cancer Treatment Resistance." This innovative research project aims to develop novel...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $862,398 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Fred Hutchinson Cancer Center in Seattle, WA. The grant, running from August 1, 2025 to July 31, 2030, will support research to selectively target and eliminate the HIV/SIV reservoir in T follicular helper cells using novel anti-PD-1 chimeric antigen receptor (CAR) T cells. The research aims to develop safer and more...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $857,346 Project Grant under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) to the Fred Hutchinson Cancer Center. The grant, awarded on January 17, 2025, supports research to define the activating and inhibitory signals in the form of cytokines and metabolites that are present in healthy and infected human tissues to regulate the effector function of CD8 T cells. This research aims to...
- This $220,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855) will support research at the Fred Hutchinson Cancer Center in Seattle, Washington. The project aims to use a novel cell lineage tracing method called ASAP-seq to identify and characterize HIV-specific memory natural killer (NK) cells in a cohort of HIV-infected women. This will help elucidate the role of NK...